Goldman Myla Lai is Director of Akoya Biosciences, Inc.. Currently has a direct ownership of 0 shares of AKYA, which is worth approximately $0. The most recent transaction as insider was on Jul 08, 2025, when has been sold 20,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

GOLDMAN MYLA LAI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2025
SELL
Other acquisition or disposition
-
20,000 Reduced 100.0%
0 Common Stock
Jun 12 2023
BUY
Open market or private purchase
$100,000 $5.0 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

WST
WEST PHARMACEUTICAL SERVICES INC Healthcare
QTRX
Quanterix Corp Healthcare
GML

Goldman Myla Lai

Director
Exton, PA

Track Institutional and Insider Activities on AKYA

Follow Akoya Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKYA shares.

Notify only if

Insider Trading

Get notified when an Akoya Biosciences, Inc. insider buys or sells AKYA shares.

Notify only if

News

Receive news related to Akoya Biosciences, Inc.

Track Activities on AKYA